Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-08-21

FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals Inc., indicating a label or indication update to the existing pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMNESTEEM (isotretinoin)

Snippet

SUPPL AP for AMNESTEEM (ISOTRETINOIN)